Brind.

Entities / Person

Dorothy Fink.

American endocrinologist

Seen in 2 reportsLast reported Saturday

Reports this week: 1
Active events: 1
Connections: 4

What's happening

Reports per dayLast 90 days

90 days agoDrag either end to show only events that began in that periodToday

Active this week

Dorothy Fink discussed FDA policy changes concerning estrogen, which was reported by USA Today.

Some support1 report

One to three months ago

Dorothy Fink, who serves as deputy director, is involved in research on testosterone at the Eunice Kennedy Shriver National Institute of Child Health and Human Development in Toronto.

Some support1 report

Around Dorothy Fink this week

News at the entities that move Dorothy Fink most

FDA Mentioned together
FDA removed warnings from HRT products, and a meeting is scheduled in Chicago involving researchers from Clalit Health Services.

Moves Dorothy Fink
05:51

Connections

The 2 strongest of 4, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.

Eunice Kennedy Shriver National Institute of Child Health and Human Development Structural

Dorothy Fink holds the formal and functional role of Deputy Director within the Institute.

Some supportSep 26

Dorothy Fink → Eunice Kennedy Shriver National Institute of Child Health and Human Development
Eunice Kennedy Shriver National Institute of Child Health and Human Development → Dorothy Fink
FDA Mentioned together

Dorothy Fink commented on FDA policy changes regarding estrogen.

Some supportSat 03:03

Dorothy Fink → FDA
FDA → Dorothy Fink

History

Events by the month they began

October 2026

1 event

Oct 31, 2026Dorothy Fink discussed FDA policy changes concerning estrogen, which was reported by USA Today.

September 2026

1 event

Sep 26, 2026Dorothy Fink, who serves as deputy director, is involved in research on testosterone at the Eunice Kennedy Shriver National Institute of Child Health and Human Development in Toronto.